Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans
- 1 July 2014
- journal article
- research article
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 8 (7) , 475-480
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseasesPharmacology & Therapeutics, 2010
- CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease—The ENCORE TrialsAtherosclerosis, 2009
- Hyperaldosteronism Among Black and White Subjects With Resistant HypertensionHypertension, 2002
- Blood Pressure Responses to Small Doses of Amiloride and Spironolactone in Normotensive SubjectsHypertension, 2001
- Genetic Variants in the Epithelial Sodium Channel in Relation to Aldosterone and Potassium Excretion and Risk for HypertensionHypertension, 1999
- Association of hypertension with T594M mutation in β subunit of epithelial sodium channels in black people resident in LondonThe Lancet, 1998
- Salt Sensitivity of Blood Pressure in HumansHypertension, 1996
- A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.Proceedings of the National Academy of Sciences, 1995
- Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndromeNature Genetics, 1995
- Studies of the control of plasma aldosterone concentration in normal manJournal of Clinical Investigation, 1972